Kallyope
Pre-clinicalAt Kallyope, we are leveraging insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders.
Founded
2015
Focus
Small Molecules
About
At Kallyope, we are leveraging insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders.
Funding History
3Total raised: $222M
Series C$112MMubadala CapitalNov 15, 2021
Series B$66MThe Column GroupOct 15, 2018
Series A$44MThe Column GroupOct 15, 2015
Company Info
TypePrivate
Founded2015
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile